Poly (ADP-ribose) polymerase 1 expression in fibroblasts of Down syndrome subjects

Down syndrome (DS) is the most common chromosomal disorder. It is featured by intellectual disability and is caused by trisomy 21. People with DS can develop some traits of Alzheimer disease at an earlier age than subjects without trisomy 21. Apoptosis is a programmed cell death process under both normal physiological and pathological conditions. Poly (ADP-ribose) polymerase 1 is a mediator of programmed-necrotic cell death and appears to be also involved in the apoptosis. The aim of the present work was to detect the intracellular distribution of PARP-1 protein using immunofluorescence techniques and the expression of PARP-1 mRNA in culture of fibroblasts of DS subjects. The analysis of the intracellular distribution of PARP-1 show a signal at the nuclear level in about 75 % of the cells of DS subjects with a slight uniformly fluorescent cytoplasm. In contrast, in about 65% of the analyzed fibroblasts of the normal subjects only a slight fluorescent was found. These observations have been confirmed by PARP-1 gene mRNA expression evaluation. The data obtained from this study strengthen the hypothesis that the over-expression of PARP-1 gene could have a role in the activation of the apoptotic pathways acting in the neurodegenerative processes in DS.

[1]  P. Bosco,et al.  Differential expression of PARP1 mRNA in leucocytes of patients with Down’s syndrome , 2011, Journal of Genetics.

[2]  P. Cole,et al.  The DNA-Binding Domain of Human PARP-1 Interacts with DNA Single-Strand Breaks as a Monomer through Its Second Zinc Finger , 2011, Journal of molecular biology.

[3]  J. McMurray,et al.  Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression. , 2011, Blood.

[4]  N. Tanimoto,et al.  PARP1 Gene Knock-Out Increases Resistance to Retinal Degeneration without Affecting Retinal Function , 2010, PloS one.

[5]  M. Hottiger,et al.  The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. , 2008, Frontiers in bioscience : a journal and virtual library.

[6]  S. Elmore Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[7]  T. Dawson,et al.  Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death , 2006, Proceedings of the National Academy of Sciences.

[8]  R. Koehler,et al.  Poly(ADP-ribose) (PAR) polymer is a death signal , 2006, Proceedings of the National Academy of Sciences.

[9]  M. Hottiger,et al.  Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going? , 2006, Microbiology and Molecular Biology Reviews.

[10]  V. Schreiber,et al.  Poly(ADP-ribose): novel functions for an old molecule , 2006, Nature Reviews Molecular Cell Biology.

[11]  B. Tycko,et al.  Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21 , 2006, BMC Medical Genetics.

[12]  Csaba Szabó,et al.  Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors , 2005, Nature Reviews Drug Discovery.

[13]  D. Warburton,et al.  Trisomy recurrence: a reconsideration based on North American data. , 2004, American journal of human genetics.

[14]  T. Dawson,et al.  Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor , 2002, Science.

[15]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[16]  G. Capone,et al.  Down syndrome: advances in molecular biology and the neurosciences. , 2001, Journal of developmental and behavioral pediatrics : JDBP.

[17]  D S Newberger,et al.  Down syndrome: prenatal risk assessment and diagnosis. , 2000, American family physician.

[18]  H. Wiśniewski,et al.  Alzheimer's disease in Down's syndrome , 1985, Neurology.